COMMUNIQUÉS West-GlobeNewswire

PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
27/03/2025
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune ® HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., March 27, 2025 (GLOBE [...]
Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update
27/03/2025
154 patients enrolled TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic [...]
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
27/03/2025
Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing [...]
Immatics Announces Full Year 2024 Financial Results and Business Update
27/03/2025
Randomized-controlled Phase 3 trial, SUPRAME, to evaluate ACTengine® IMA203 TCR-T (PRAME) in advanced melanoma patients; first patient randomized and enrollment continues as planned ACTengine® IMA203 TCR-T (PRAME): [...]
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
27/03/2025
WATERTOWN, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
27/03/2025
The presentation will be webcast at 1:30 PM ET on April 10, 2025 POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, [...]
TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access
27/03/2025
Mr. Camiolo brings to TScan demonstrated commercial readiness and cell therapy launch experience WALTHAM, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology [...]
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
27/03/2025
– Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class blocking [...]
Microbix Announces Annual and Special Meeting Voting Results
27/03/2025
MISSISSAUGA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the “ Company ”), a life sciences innovator and exporter, announces the voting results from [...]
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
27/03/2025
First Analysis from Phase 1b Study of GT-02287 in Parkinson’s Disease Expected in Q2 2025 BETHESDA, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical- [...]
BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones
27/03/2025
Plinabulin Final Phase 3 Data Published in The Lancet Respiratory Medicine , Demonstrating Overall Survival Benefit in 2L/3L NSCLC EGFR Wild Type vs. Docetaxel Plinabulin Phase 2 Data Highlights Potential to Resensitize [...]
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
27/03/2025
Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary Perforations WAYNE, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical [...]
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
27/03/2025
STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy
27/03/2025
AURORA, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and other forms of chronic nerve discomfort. [...]
Zelluna ASA [ZLNA]: Share capital increase registered
27/03/2025
Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 26 March 2025 regarding the resolution of the board of directors of Zelluna ASA (the " Company ") to carry out a share capital [...]
LE QUÉBEC RATE UNE OCCASION DE GÉNÉRER DES REVENUS POUR LA SANTÉ PUBLIQUE
27/03/2025
MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- Avec déception, le Collectif Vital a constaté que le financement de la santé publique accuse un recul dans le budget 2025-2026 du ministre des Finances. La taxation des [...]
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27/03/2025
Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad [...]
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27/03/2025
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Pleco Therapeutics annonce un résultat positif de sa réunion de pré-IND avec la FDA pour la poursuite du développement du PTX-252 dans le cadre du traitement de la leucémie myéloïde aiguë
27/03/2025
NIMÈGE, Pays-Bas, 27 mars 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, société biopharmaceutique de phase clinique qui développe des thérapies innovantes pour les cancers difficiles à traiter, annonce un résultat [...]

Pages